PAMU
HAE icon

Pictet Asset Management (UK)’s Haemonetics HAE Stock Holding History

Pictet Asset Management (UK)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$213K Sell
3,200
-1,000
-24% -$70.8K ﹤0.01% 1607
2021
Q1 		$466K Hold
4,200
– – ﹤0.01% 1225
2020
Q4 		$499K Hold
4,200
– – ﹤0.01% 1166
2020
Q3 		$366K Buy
+4,200
New +$367K ﹤0.01% 1158

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Pictet Asset Management (UK)'s HAE Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Haemonetics (HAE) stake by 24% in Q2 2021, selling an estimated $70.8K and leaving 3,200 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1607.

Pictet Asset Management (UK) first reported a position in HAE in Q3 2020 and has held it in 4 quarters since. The position peaked at $499K in Q4 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • Pictet Asset Management (UK) held 3,200 shares of Haemonetics worth $213K as of Q2 2021.
  • Pictet Asset Management (UK) sold 1,000 Haemonetics shares in Q2 2021, an estimated $70.8K.
  • Haemonetics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1607 holding.
  • Pictet Asset Management (UK) first reported a position in Haemonetics in Q3 2020 and has held it in 4 quarters since.
  • Pictet Asset Management (UK)'s Haemonetics position peaked at $499K in Q4 2020.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.